174. South Asian J Cancer. 2018 Apr-Jun;7(2):156-158. doi: 10.4103/sajc.sajc_126_18.Practical consensus recommendations for neo-adjuvant chemotherapy in triplenegative breast cancer.Bhattacharyya GS(1), Walia M(2), Nandi M(3), Murli A(4), Salim S(5), RajpurohitS(6), Shinde S(7), Aggarwal S(7), Parikh PM(8).Author information: (1)Department of Medical Oncology, Fortis Hospital, Kolkata, West Bengal, India.(2)Department of Medical Oncology, Max Hospital, New Delhi, India.(3)Department of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India.(4)Department of Medical Oncology, Sarvodaya Hospital, Faridabad, Haryana, India.(5)Department of Oncology, Hakim Sanaullah Cancer Center, Sopore, Jammu andKashmir, India.(6)Department of Medical Oncology, RGCI, New Delhi, India.(7)Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India.(8)Department of Oncology, Shalby Cancer and Research Institute, Mumbai,Maharashtra, India.This manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to use neoadjuvant chemotherapy in triple negativebreast cancer patients.DOI: 10.4103/sajc.sajc_126_18 PMCID: PMC5909296PMID: 29721485 